Enhanced Capital
Enhanced Capital Partners, founded in 1999 and headquartered in New York, is a national investment firm that specializes in equity and debt investments in small and mid-sized companies across the United States. With over $400 million under management, the firm employs a flexible investment strategy aimed at promoting the growth and expansion of businesses. Enhanced Capital focuses on various sectors, including healthcare technology and technology, media, and telecommunications. As a subsidiary of P10 Holdings, it seeks to maximize the growth potential of companies poised for rapid development through its practical investment approach.
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.
NovaTract Surgical, Inc. is a medical device company focused on enhancing minimally invasive surgical practices. Founded in 2010 and based in Connecticut, the company develops innovative solutions such as NovaGrasp, a single-use laparoscopic grasper for tissue and organ retraction, and NovaTract, a dynamic retractor for various minimally invasive surgeries, including colorectal, urologic, gynecologic, and robotic-assisted procedures. NovaTract Surgical aims to address the growing fields of single-incision laparoscopic surgery and natural orifice transluminal endoscopic surgery, providing advanced tools to improve surgical outcomes for healthcare institutions and surgeons.